Reference 2018-191

REF:            2018-191

Subject:        Non-Valvular Atrial Fibrillation

 

 

Request:

In your trust how many patients in the latest 3 months that you have available, have been treated with the drugs below:

Apixaban

Dabigatran

Edoxaban

Rivaroxaban

Warfarin

Heparin.

 

If you are unable to provide the information by the number of patients, we will be happy to accept a response in relation to the number of drugs that have left the pharmacy.

 

 

Response:

Apixaban 34,192 tablets
Dabigatran 300 capsules
Edoxaban 216 tablets
Rivaroxaban 4,286 tablets
Warfarin 13,244 tablets
Heparin 602 injections